🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Danielle M. DiFranco

University of Arizona

ORCID: 0000-0002-6477-7658

Also affiliated with University of Michigan

NeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice”.

ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.18.500473
N/A
0DataRank · unranked
2 citations

Annie J. Zalon, Danielle M. DiFranco, Alexandra F. Putka, Nicholas R. Stec, Sabrina I. Jarrah +6 more

Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3

Frontiers in Neuroscience(2023)10.3389/fnins.2023.1118429
N/A
0DataRank · unranked
17 citations

Danielle M. DiFranco, Alexandra F. Putka, Juan P. Mato, Sabrina I. Jarrah, Nicholas R. Stec +3 more

ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice

Molecular Therapy(2024)10.1016/j.ymthe.2024.02.033
N/A
0DataRank · unranked
20 citations

Annie J. Zalon, Danielle M. DiFranco, Alexandra F. Putka, Nicholas R. Stec, Sabrina I. Jarrah +6 more